<DOC>
	<DOCNO>NCT02033135</DOCNO>
	<brief_summary>This randomize clinical study intend evaluate use Zilver PTX stent treatment thigh atherosclerosis . Research question : Is adjuvant benefit angioplasty stenting use new paclitaxel elute stent , Zilver-PTX , risk factor modification medical therapy alone patient stable , mild moderate intermittent claudication cause femoropopliteal lesion suitable endovascular management .</brief_summary>
	<brief_title>Paclitaxel Eluting Stent Exercise Thigh Atherosclerosis</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>Patient sign date informed consent . Patient 1 2 document stenotic occlude atherosclerotic lesion ( 18 cm long ) abovetheknee femoropopliteal artery , meet inclusion criterion none exclusion criterion . Reference vessel ( abovetheknee femoropopliteal artery ) diameter 4 mm 9 mm . Taget lesion ( ) accessible stenting , image angiography ( digital subtraction , MRI CTI ) , i.e . proximal cm SFA must open Patient de novo restenotic lesion ( ) &gt; 50 % stenosis document angiographically prior stent target lesion . Patient symptoms peripheral arterial disease classify Rutherford Category 2 ( moderate claudication ) 3 ( severe claudication ) last least 3 month . ( Positive Claudication Questionnaire ) Exercise therapy , smoke cessation advise best medical therapy must implement least 3 month ago without significant clinical effect . Patient rest ABI &lt; 0.9 abnormal exercise ABI ( decrease 0.15 ) rest ABI normal . Patient incompressible artery ( ABI &gt; 1.2 ) must TBI &lt; 0.8 . Patient agree return clinical status assessment duplex ultrasound 6 week , 6 month , 12 month , 24 month . Patient pregnant , breastfeed 18 year age . Patient unable understand sign inform consent form Patient simultaneously participate another investigational drug device study . Patient plan surgical interventional procedure within 30 day study procedure . Patient antiplatelet and/or anticoagulant therapy contraindicate . Patient known hypersensitivity contraindication aspirin , antiplatelet medication , contrast dye , paclitaxel nitinol . Patient 23 patent crural vessel runoff &lt; 50 % stenosis throughout course . Activity limit comorbid condition claudication , example : severe coronary artery disease ; angina pectoris ; chronic lung disease ; neurological disorder hemiparesis ; arthritis , musculoskeletal condition include amputation BMI &gt; 40 Other active significant medical problem cancer , know chronic renal disease ( serum creatinine great 2.0 mg/dl within 60 day renal replacement therapy ) , know chronic liver disease anaemia , active substance abuse , know history dementia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Intermittent claudication</keyword>
	<keyword>Angioplasty</keyword>
</DOC>